John Panagides

2.0k citations

71 papers · 1.5k indexed · h-index 22

Impact in

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Epilepsy research and treatment
Biological Psychiatry top 5%

Papers in

Psychiatry and Mental health 36
- Schizophrenia research and treatment 28
- Bipolar Disorder and Treatment 18
- Electroconvulsive Therapy Studies 11
- Epilepsy research and treatment 6
- Attention Deficit Hyperactivity Disorder 4
Biological Psychiatry 3

Co-authors: Jun ZhaoLarry Alphs Miriam Cohen Thomas A. Macek Roger S. McIntyre Armin Szegedi John M. Kane Mary Mackle
Journals: European Neuropsychopharmacology (8 papers)Schizophrenia Research (6 papers)European Psychiatry (5 papers)Journal of Affective Disorders (4 papers)Pharmacopsychiatry (3 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

John Panagides

68 papers receiving 1.5k citations

Peers

Countries citing papers authored by John Panagides

Since Specialization

Citations

This map shows the geographic impact of John Panagides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Panagides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Panagides more than expected).

Fields of papers citing papers by John Panagides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Panagides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Panagides. The network helps show where John Panagides may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Panagides, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Panagides Line = papers co-authored together John Panagides links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IMIL: Interactive Medical Image Learning Framework Georg Reiss, Andrea Fisher, Lohitha Kethu, John Panagides, Katherine McNamara, J�ri Allik, Oliver Aalami	2024	2
2	The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities Cancers ·Arian Mansur, İncinur Hanik Sevim, Yuan Sun, W.D. Satterfield, John Panagides, J. Ürmösi, Shams Iqbal, Dania Daye	2023	25
3	A machine learning algorithm predicting risk of dilating VUR among infants with hydronephrosis using UTD classification Journal of Pediatric Urology ·Hsin‐Hsiao Scott Wang, Michael Li, Maria Beltran-Rodriguez, John Panagides, Tanya Logvinenko, Jeanne S. Chow, Caleb P. Nelson	2023	3
4	New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel Journal of Vascular and Interventional Radiology ·Dania Daye, John Panagides, Larry Norton, Muneeb Ahmed, Eisuke Fukuma, Robert C. Ward, Daniel R. Gomez, Nima Kokabi, Thomas J. Vogl, Nadine Abi‐Jaoudeh, Amy R. Deipolyi	2023	1
5	Interpretable Machine Learning for the Prediction of Amputation Risk Following Lower Extremity Infrainguinal Endovascular Interventions for Peripheral Arterial Disease CardioVascular and Interventional Radiology ·Guido Latre, Nicholas Reid, John Panagides, John Di Capua, Charles DeCarlo, Anahita Dua, Sanjeeva P. Kalva, Jayashree Kalpathy–Cramer, Dania Daye	2022	14
6	Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions PLoS ONE ·Thomas J. Moutinho, John Panagides, Matthew B. Biggs, Gregory L. Medlock, Glynis L. Kolling, Jason A. Papin	2017	21
7	Training for Assessment of Negative Symptoms of Schizophrenia across Languages and Cultures: Comparison of the NSA-16 with the PANSS Negative Subscale and Negative Symptom Factor Clinical Schizophrenia & Related Psychoses ·David G. Daniel, Larry Alphs, Pilar Cazorla, John J. Bartko, John Panagides	2011	19
8	Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder Journal of Clinical Psychopharmacology ·Armin Szegedi, Joseph R. Calabrese, Charles L. Bertrand, Mary Mackle, Jun Zhao, John Panagides	2011	57
9	A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment The Journal of Clinical Psychiatry ·John M. Kane, Mary Mackle, J. Van Luipen, Jun Zhao, Armin Szegedi, John Panagides	2011	69
10	Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder Pharmacopsychiatry ·Tae-Sang Jung, Dieter Naber, Won Dae Cho, John Panagides, Richard Emsley	2010	66
11	Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia Journal of Clinical Psychopharmacology ·John M. Kane, Michael N. Cohen, Jun Zhao, Larry Alphs, John Panagides	2010	98
12	Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms The AAPS Journal ·Rik de Greef, Alan Maloney, Per Olsson, Tae-Sang Jung, John Panagides	2010	44
13	Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study Journal of Affective Disorders ·Roger S. McIntyre, Miriam Cohen, Jun Zhao, Larry Alphs, Thomas A. Macek, John Panagides	2010	68
14	Asenapine versus olanzapine in acute mania: a double‐blind extension study Bipolar Disorders ·Roger S. McIntyre, Miriam Cohen, Jun Zhao, Larry Alphs, Thomas A. Macek, John Panagides	2009	76
15	P.3.c.010 Asenapine safety and tolerability in acute schizophrenia: a placebo-and risperidone-controlled trial European Neuropsychopharmacology ·Steven G. Potkin, Toshiya Amari, John Panagides, Yijiang Pang	2006	2
16	Meta‐analysis of randomized, double‐blind, dacebo‐controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depression Acta Psychiatrica Scandinavica ·Stephen M. Stahl, M. Zivkov, Paul‐Egbert Reimitz, John Panagides, William G. van’t Hoff	1997	32
17	Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat meal European Journal of Drug Metabolism and Pharmacokinetics ·Mikaël Cohen, John Panagides, C. J. Timmer, Sahar Haq	1997	18
18	Utilization of medical services for the treatment of acute low back pain Journal of General Internal Medicine ·W. Scott Schroth, Joel M. Schectman, M.A. Aiad, John Panagides	1992	61
19	REMERGON EFFICACY IN MAJOR DEPRESSIVE EPISODE: A RANDOMIZED, DOUBLEBLIND, PLACEBO AND AMITRIPTYLINE-CONTROLLED STUDY. Clinical Neuropharmacology ·J. Douglas Bremner, Chieh‐Hsiang Sun, John Panagides	1992	2
20	The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis Clinical Pharmacology & Therapeutics ·M. Kraml, David Hicks, Meredith McKean, John Panagides, Johannes Fürst	1988	24

About John Panagides

John Panagides is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Pharmacology, Aging and Pediatrics, Perinatology and Child Health, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (28 papers), Bipolar Disorder and Treatment (18 papers), Treatment of Major Depression (12 papers), Electroconvulsive Therapy Studies (11 papers), Epilepsy research and treatment (6 papers), Pharmaceutical studies and practices (4 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.0k citations), Biological Psychiatry (69 citations), Pharmacology (446 citations), Health Informatics (14 citations) and Cellular and Molecular Neuroscience (154 citations). John Panagides has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Jun Zhao, Larry Alphs, Miriam Cohen, Thomas A. Macek, Roger S. McIntyre, Armin Szegedi, John M. Kane, Mary Mackle, Ward T. Smith and Vincent Glaudin. Their work appears in journals such as European Neuropsychopharmacology, Schizophrenia Research, European Psychiatry, Journal of Affective Disorders and Pharmacopsychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact